Chronic hepatitis C (HCV) infection is currently one of the most clinically relevant
comorbidities in the HIV population; overall, it affects one third of HIV-positive individuals [1] …

Cirrhosis is the end-stage consequence of fibrosis progression in patients with chronic
hepatitis C. The median time from infection to cirrhosis is 30 years, with a high inter …

Background Whereas 40 million individuals are estimated to be infected with HIV worldwide,
nearly 400 million people are chronic HBV carriers [10]. HBV and HIV are endemic in the …

Transcatheter arterial chemoembolization (TACE) offers a survival benefit to patients with
intermediate hepatocellular carcinoma (HCC). A widely accepted TACE regimen includes …

Background Liver biopsy is thought mandatory for management of patients with hepatitis C
virus (HCV) infection, especially for staging fibrosis. We aimed, in our prospective study, to …

The natural history of hepatitis C virus (HCV) infection in human immunodeficiency virus
(HIV)‐infected patients has never been studied according to the concept of liver fibrosis …

Aim: To update previous overviews of placebo‐controlled double‐blind trials assessing the
efficacy and tolerance of smooth muscle relaxants in irritable bowel syndrome. Methods and …

Background Various observations have suggested that the course of COVID-19 might be
less favourable in patients with inflammatory rheumatic and musculoskeletal diseases …

Background & Aims We performed a prospective study to investigate the effects of a
sustained viral response (SVR) on outcomes of patients with hepatitis C virus (HCV) …

Hepatitis B virus (HBV) resistance to lamivudine has not been extensively documented in
human immunodeficiency virus (HIV)‐infected patients. We studied the long‐term incidence …